Patient Attitudes and Their Awareness Towards Skin Cancer-Related Apps: Cross-Sectional Survey.
awareness
melanoma
mobile applications
patient education
skin cancer
telemedicine
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
02 07 2019
02 07 2019
Historique:
received:
27
02
2019
accepted:
18
04
2019
revised:
18
04
2019
entrez:
4
7
2019
pubmed:
4
7
2019
medline:
4
7
2019
Statut:
epublish
Résumé
In the emerging era of digitalization and electronic health, skin cancer-related apps represent useful tools to support dermatologic consultation and examination. Yet, little is known about how patients perceive the value of such apps. The aim of this study was to investigate patient attitudes and their awareness toward skin cancer-related apps. A cross-sectional study including 200 patients from the oncological outpatient unit was conducted at the University Hospital (LMU Munich, Germany) between September and December 2018. Patients were asked to complete a self-administered questionnaire on the popularity and usefulness of health-related and skin cancer-related apps. A descriptive analysis was performed with the expression of categorical variables as frequencies and percentages. For continuous variables, the median and range were indicated. Contingency tables and chi-square tests were performed to investigate associations between sociodemographic data and selected items of the questionnaire. A total of 98.9% (195/197) of patients had never used skin cancer-related apps or could not remember. In 49.7% (93/187) of cases, patients were unsure about the usefulness of skin cancer apps, whereas 42.6% (78/183) thought that skin cancer apps could supplement or support the professional skin examination performed by a physician. However, 47.9% (90/188) were interested in acquiring more information by their dermatologists about skin cancer apps. Young age (P=.002), male gender (P=.02), a previous history of melanoma (P=.004), and higher educational level (P=.002) were significantly associated with a positive attitude. Nevertheless, 55.9% (105/188) preferred a printed patient brochure on skin cancer to downloading and using an app. The experience and knowledge of skin cancer-related apps was surprisingly low in this population, although there was a high general interest in more information about such apps. Printed patient brochures were the preferred information source.
Sections du résumé
BACKGROUND
In the emerging era of digitalization and electronic health, skin cancer-related apps represent useful tools to support dermatologic consultation and examination. Yet, little is known about how patients perceive the value of such apps.
OBJECTIVE
The aim of this study was to investigate patient attitudes and their awareness toward skin cancer-related apps.
METHODS
A cross-sectional study including 200 patients from the oncological outpatient unit was conducted at the University Hospital (LMU Munich, Germany) between September and December 2018. Patients were asked to complete a self-administered questionnaire on the popularity and usefulness of health-related and skin cancer-related apps. A descriptive analysis was performed with the expression of categorical variables as frequencies and percentages. For continuous variables, the median and range were indicated. Contingency tables and chi-square tests were performed to investigate associations between sociodemographic data and selected items of the questionnaire.
RESULTS
A total of 98.9% (195/197) of patients had never used skin cancer-related apps or could not remember. In 49.7% (93/187) of cases, patients were unsure about the usefulness of skin cancer apps, whereas 42.6% (78/183) thought that skin cancer apps could supplement or support the professional skin examination performed by a physician. However, 47.9% (90/188) were interested in acquiring more information by their dermatologists about skin cancer apps. Young age (P=.002), male gender (P=.02), a previous history of melanoma (P=.004), and higher educational level (P=.002) were significantly associated with a positive attitude. Nevertheless, 55.9% (105/188) preferred a printed patient brochure on skin cancer to downloading and using an app.
CONCLUSIONS
The experience and knowledge of skin cancer-related apps was surprisingly low in this population, although there was a high general interest in more information about such apps. Printed patient brochures were the preferred information source.
Identifiants
pubmed: 31267978
pii: v7i7e13844
doi: 10.2196/13844
pmc: PMC6632106
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13844Informations de copyright
©Theresa Steeb, Anja Wessely, Sebastian Mastnik, Titus Josef Brinker, Lars Einar French, Anne-Charlotte Niesert, Carola Berking, Markus Vincent Heppt. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 02.07.2019.
Références
JMIR Mhealth Uhealth. 2017 Jun 14;5(6):e81
pubmed: 28615159
Eur J Cancer. 2017 Apr;75:47-55
pubmed: 28214657
Hautarzt. 2018 Apr;69(4):335-339
pubmed: 29396641
Telemed J E Health. 2017 Dec;23(12):948-954
pubmed: 28562195
Dermatol Pract Concept. 2017 Apr 30;7(2):1-6
pubmed: 28515985
Support Care Cancer. 2009 Aug;17(8):1117-28
pubmed: 19319577
Nature. 2017 Jun 28;546(7660):686
pubmed: 28658222
Ann Oncol. 2007 Mar;18(3):479-84
pubmed: 17272832
Inform Health Soc Care. 2018 Dec;43(4):390-400
pubmed: 29256715
Healthc (Amst). 2014 Jul;2(2):94-8
pubmed: 26250375
J Med Internet Res. 2017 Apr 19;19(4):e125
pubmed: 28428170
Ann Oncol. 2018 Aug 1;29(8):1836-1842
pubmed: 29846502
Int J Surg. 2014 Dec;12(12):1495-9
pubmed: 25046131
Support Care Cancer. 2008 Oct;16(10):1189-95
pubmed: 18293014
J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1170-8
pubmed: 23962170
J Cancer Educ. 2015 Sep;30(3):580-4
pubmed: 25077770
Melanoma Res. 2016 Feb;26(1):71-6
pubmed: 26426762
JMIR Mhealth Uhealth. 2018 Mar 09;6(3):e60
pubmed: 29523502
J Dtsch Dermatol Ges. 2018 Sep;16(9):1093-1101
pubmed: 30091517
J Cancer Educ. 2019 Aug;34(4):760-767
pubmed: 29736794
JAMA Dermatol. 2018 Sep 1;154(9):1085-1086
pubmed: 30046805
Ecancermedicalscience. 2011;5:235
pubmed: 22276067
JMIR Mhealth Uhealth. 2017 Jul 26;5(7):e101
pubmed: 28747297
Int J Surg. 2014 Dec;12(12):1500-24
pubmed: 25046751
N Engl J Med. 2017 Oct 5;377(14):1345-1356
pubmed: 28889792
Int J Cancer. 2013 Jan 15;132(2):385-400
pubmed: 22532371
JMIR Res Protoc. 2015 Jul 15;4(3):e85
pubmed: 26177562
Eur J Surg Oncol. 2017 Aug;43(8):1528-1535
pubmed: 28684059
JMIR Mhealth Uhealth. 2018 Apr 26;6(4):e103
pubmed: 29699971